You've been automatically redirected here from, which is now part of Proteintech Group. Click here to dismiss this alert.

AMPK Signaling: New Pathway Poster

Download a pathway poster for your lab

All the posters in the Proteintech library are available in PDF format or can be requested as a hard copy.

AMPK Pathway Overview

One of the central regulators of cellular and organismal metabolism in eukaryotes is AMP-activated protein kinase (AMPK). AMPK is a master regulator of cellular energy homeostasis and has recently been connected to cellular processes such as autophagy and cell polarity (1). AMPK has also been implicated in several species as a critical modulator of aging through its interactions with mTOR or sirtuins. The kinase is activated in response to stresses that deplete cellular ATP supplies such as low glucose, hypoxia, ischemia, and heat shock. In mammals, there are two genes encoding the AMPK α catalytic subunit (α1 and α2), two β genes (β1 and β2), and three γ subunit genes (γ1, γ2, and γ3) (2).

Due to its role as a central regulator of both lipid and glucose metabolism, AMPK is considered to be a potential therapeutic target for the treatment of type II diabetes mellitus, obesity, and cancer (3 and 4).

Download the AMPK Pathway here

Related Antibodies

AKT1 Insulin
AMPK Alpha 1 KD/KO Validated LKB1
CD36  P21;CDKN1A
CPT1A p53 KD/KO Validated
Browse more pathway posters here

Request a printed poster

I consent to having Proteintech store my submitted information so they can respond to my enquiry.

By completing this form you are agreeing to receive email communication from Proteintech. Personal data submitted will be processed in accordance with applicable data protection regulations and Proteintech’s privacy policy. You can unsubscribe at any time and update or remove personal data by contacting Proteintech.


1. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

2.. AMPK activators: mechanisms of action and physiological activities

3. AMPK: an emerging drug target for diabetes and the metabolic syndrome.

4. Targeting AMPK for cancer prevention and treatment



25 May, 2017


to top